• Selective IRAP Inhibition: Bestatin-Derived Nanomolar Inhibi

  2026-06-25

  This study introduces highly selective, nanomolar inhibitors of insulin-regulated aminopeptidase (IRAP) based on α-hydroxy-β-amino acid derivatives of Bestatin. The work provides structural and mechanistic insights into inhibitor design, with implications for targeted aminopeptidase regulation in cancer and immunology research.

• Bacillus Strains and Media Shape γ-Glutamyl Peptide Producti

  2026-06-25

  This study systematically investigates how different Bacillus strains and growth media modulate the production of γ-glutamyl peptides, particularly di- and tripeptides, with implications for kokumi taste enhancement and glutathione pathway research. The findings highlight the critical roles of substrate selection and microbial metabolism, providing actionable insights for researchers in food biotechnology and peptide biochemistry.

• QX77: Advanced Mechanistic Insights for Autophagy and Stem C

  2026-06-24

  Discover how QX77, a molecular chaperone activator, uniquely enables precise autophagy pathway modulation and stem cell differentiation studies. This deep-dive article explores mechanisms, protocol optimization, and actionable insights beyond existing resources.

• Dimethyloxalylglycine (DMOG): Technical Guide & Protocol Par

  2026-06-23

  Dimethyloxalylglycine (DMOG) enables researchers to model hypoxia-induced cellular responses by stabilizing hypoxia-inducible factors through competitive inhibition of prolyl-4-hydroxylase domain enzymes in vitro and in vivo. It is not intended for diagnostic or clinical use and requires strict adherence to technical protocols for reliable results.

• Comparative Antibacterial Activities of Cefoperazone and MK0

  2026-06-23

  Cullmann et al. systematically compared the in vitro antibacterial activities of N-formimidoyl thienamycin (MK0787) and several recently developed β-lactam antibiotics, including cefoperazone, against a diverse panel of resistant bacterial clinical isolates. Their findings clarify the nuanced activity profiles and β-lactamase stability of these agents, providing a robust foundation for future research on gram-negative resistance and assay optimization.

• AICAR and AMPK: Strategic Insights for Translational Researc

  2026-06-22

  AMPK activation by AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) offers a mechanistic bridge between cellular energetics and inflammation control. This article provides translational researchers with a synthesis of mechanistic evidence, protocol guidance, and strategic context for deploying AICAR in metabolic and immunoinflammatory studies, with a focus on obesity-related asthma and beyond.

• BMS-345541: Unraveling Angiogenesis and Inflammation via IKK

  2026-06-22

  Explore how BMS-345541, a potent IKK-1/IKK-2 inhibitor, enables advanced inflammation and angiogenesis research by dissecting Notch/NF-κB pathway dynamics. Discover new experimental insights and assay guidance beyond standard protocols.

• Monomeric Amyloid Beta Regulates Microglia in Brain Developm

  2026-06-21

  Kwon et al. (2024) reveal a previously unrecognized signaling pathway in which monomeric amyloid beta-peptide (Aβ) inhibits microglial activation during mouse neocortical development. This finding expands the physiological roles of Aβ, suggesting that depletion of its monomeric form may contribute to neurodevelopmental disruption and Alzheimer's disease pathology.

• Functional Genomic Screens Clarify Drug-Induced Cell Death M

  2026-06-20

  Honeywell et al. introduce MEDUSA, a simulation-assisted approach that disentangles growth and death rates in functional genomic screens to reveal how drugs induce cell death. This method exposes key regulators of both apoptotic and non-apoptotic lethality, improving precision in mapping drug action and informing therapeutic strategy.

• Palomid 529 in Cancer Research: Protocols, Advantages & Trou

  2026-06-19

  Palomid 529 (P529) stands out as a dual mTORC1/mTORC2 inhibitor, uniquely enabling researchers to dissect PI3K/Akt/mTOR signaling and overcome resistance in cancer models. Discover stepwise protocols, application nuances, and expert troubleshooting tips that maximize its translational impact across oncology and radiotherapy enhancement.

• gamma-Glu-Cys (γ-Glu-Cys): Advanced Insights for Thiol Pepti

  2026-06-19

  Explore the pivotal role of gamma-Glu-Cys (γ-Glu-Cys) in thiol-reactive peptide synthesis, glutathione metabolism, and plant stress adaptation. This article delivers an original analysis of substrate selection strategies, drawing on recent scientific advances and practical assay optimization.

• Bacillus Strains and Media Shape γ-Glu-Cys Peptide Productio

  2026-06-18

  This study systematically dissects how Bacillus species and growth media composition influence the biosynthesis of γ-glutamyl peptides, including γ-Glu-Cys, with a focus on hemoglobin hydrolysate and brain heart infusion substrates. The findings offer actionable insight for optimizing glutathione metabolism research and kokumi peptide engineering workflows.

• Bacillus Strains and Media Shape γ-Glutamyl Peptide Profiles

  2026-06-18

  This study systematically dissects how Bacillus strain selection and growth medium composition influence the generation of γ-glutamyl peptides, including glutathione. The findings demonstrate that medium composition exerts a stronger effect than strain identity, informing both food biotechnology and glutathione metabolism research.

• Canagliflozin: SGLT2 Inhibitor Workflows for Renal Research

  2026-06-17

  Canagliflozin is redefining diabetes and kidney disease research by enabling targeted modulation of glucose reabsorption and mitochondrial function in preclinical models. This guide details experimental workflows, protocol optimizations, and troubleshooting strategies that leverage APExBIO’s Canagliflozin for robust metabolic and renal studies.

• Pregnenolone-16α-carbonitrile Suppresses Hippocampal CYPs vi

  2026-06-17

  This study reveals that pregnenolone 16α-carbonitrile (PCN) downregulates hippocampal cytochrome P450 enzymes and protects against phenytoin-induced neurotoxicity in mice, acting through a glucocorticoid receptor (GR)-dependent, but PXR-independent, pathway. The findings highlight a novel central nervous system action of PCN, suggesting new avenues for mitigating adverse neurological effects of antiepileptic drugs.

460 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page